Donafenib for Previously Treated Metastatic Colorectal Cancer

Summary

The investigators do the clinical trial (patients with metastatic colorectal cancer treated with donafenib/placebo after failure of standard therapy) to assess efficacy and safety of donafenib in patients with metastatic colorectal cancer, progressing after all approved standard therapies.

Timeline

Start

2016-12-28

Primary completion

2020-04-30

Completion

2020-04-30

Drugs

Indications